The aim of the project is to conduct pioneering research and clinical trials in the use of stem cells as a therapeutic modality in the prevention and treatment of diseases that result in disability.
Summary
As the use of adult, cord, and embryonic stem cells in a variety of disciplines ranging from gene therapy to modulating cell cycle and differentiation is increasing, the need to establish reliable methodologies for stem cell processing, characterization, storage, and therapeutic use, has become a priority. The research and clinical trials will bring together the research team and the clinician as they plan clinical trials for the prevention and treatment of disability causing diseases like neuromuscular, neurodegenerative, cardiovascular, renal, liver and autoimmune diseases, brain and spinal cord injuries, diabetes, and cancer. Further, this project will facilitate the exchange of knowledge and technology between the Kingdom of Saudi Arabia and Switzerland, thereby providing training opportunities for Saudi and Swiss nationals resulting in capacity building in the area of stem cell reseach and benefit to global, and in particular, Arab healthcare.
Our collaborator, the Swiss Stem Cell Bank (SSCB) in Lugano, Switzerland, is a modern laboratory equipped with state-of-the-art technology and being managed by highly qualified and accredited scientists and physicians who are currently engaged in research and development of new stem cell based therapies. The laboratory is actively collaborating with the University of Zurich, Switzerland. Our partner for this project is The King Faisal Specialist Hospital and Research Centre.